These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10717341)

  • 1. A model to estimate the probability of hepatitis B- and Haemophilus influenzae type b-vaccine uptake into national vaccination programs.
    Miller MA; Flanders WD
    Vaccine; 2000 Apr; 18(21):2223-30. PubMed ID: 10717341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
    Miller MA; McCann L
    Health Econ; 2000 Jan; 9(1):19-35. PubMed ID: 10694757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity.
    Nolan T; Hogg G; Darcy MA; Skeljo M; Carlin J; Boslego J
    Vaccine; 2001 Feb; 19(15-16):2127-37. PubMed ID: 11228385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S; Reyes M; Bernal N; Lefevre I; David MP; Han HH; Bock HL; Wolter J; Schuerman L
    Hum Vaccin; 2005; 1(5):198-203. PubMed ID: 17012860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule.
    Avdicová M; Prikazský V; Hudecková H; Schuerman L; Willems P
    Eur J Pediatr; 2002 Nov; 161(11):581-7. PubMed ID: 12424582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine. Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation schedule.
    Fagnani F; Le Fur C; Durand I; Gibergy M
    Eur J Health Econ; 2004 Jun; 5(2):143-9. PubMed ID: 15452751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.
    Tregnaghi M; López P; Rocha C; Rivera L; David MP; Rüttimann R; Schuerman L
    Rev Panam Salud Publica; 2006 Mar; 19(3):179-88. PubMed ID: 16640847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines.
    Brinsmead R; Hill S; Walker D
    Pediatr Infect Dis J; 2004 Jan; 23(1):32-7. PubMed ID: 14743043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.
    DeStefano F; Mullooly JP; Okoro CA; Chen RT; Marcy SM; Ward JI; Vadheim CM; Black SB; Shinefield HR; Davis RL; Bohlke K;
    Pediatrics; 2001 Dec; 108(6):E112. PubMed ID: 11731639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children.
    Santos JI; Martin A; De Leon T; Rivera L; Gaitán ME; Del Rio C; Oselka G; Cervantes Y; Rubio P; Clemens SA; de Mendonça JS
    Vaccine; 2002 Mar; 20(13-14):1887-93. PubMed ID: 11906779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.
    Faingezicht I; Avila-Aguerro ML; Cervantes Y; Fourneau M; Clemens SA
    Rev Panam Salud Publica; 2002 Oct; 12(4):247-57. PubMed ID: 12431356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine.
    de Almeida AE; de Filippis I; Abreu AO; Ferreira DG; Gemal AL; Marzochi KB
    Braz J Med Biol Res; 2005 May; 38(5):777-81. PubMed ID: 15917960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccine against Haemophilus influenzae type b. A new great achievement in the research on vaccines].
    Solberg CO; Brandtzeeg P
    Tidsskr Nor Laegeforen; 1995 May; 115(13):1597-8. PubMed ID: 7778070
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.
    Kanra G; Kara A; Demiralp O; Contorni M; Hilbert AK; Spyr C; Viviani S
    Hum Vaccin; 2006; 2(4):155-60. PubMed ID: 17012890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV Combination vaccine co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age.
    Gabutti G; Zepp F; Schuerman L; Dentico P; Bamfi F; Soncini R; Habermehl P; Knuf M; Crovari P;
    Scand J Infect Dis; 2004; 36(8):585-92. PubMed ID: 15370670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.